Figure 1

MACE breakdown by event type in RA and PsA. AS is not represented here as there were no MACE. ADA, adalimumab; CV, cardiovascular; E, events; E/100, events per 100; EAIR; exposure-adjusted incidence rate (n/100 PY); EOW, every other week; MACE, major adverse cardiovascular events; MI, myocardial infarction; MTX, methotrexate; PsA, psoriatic arthritis; PY, patient-years; QD, once daily; RA, rheumatoid arthritis; UPA, upadacitinib.